Saturday, February 23, 2013

• Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS® (peginesatide) InjectionBusiness Wire (Sat, Feb 23)

Tuesday, February 19, 2013

• AFFYMAX: A Binary Playat Seeking Alpha (Tue, Feb 19)

Monday, February 18, 2013

• U.S. Food and Drug Administration Approved 30% More Drugs in 2012Marketwired (Mon, Feb 18)

Friday, February 15, 2013

• Dow's Bumpy Ride Keeps It in Positive Territoryat Motley Fool (Fri, Feb 15)
• Intrepid Potash Estimates Deemed Too High and 4 Stock Analyses Making Roundsat Wall St. Cheat Sheet (Fri, Feb 15)

Thursday, February 14, 2013

• 4 Healthcare Stock Stories Prescribed for Investorsat Wall St. Cheat Sheet (Thu, Feb 14)
• 5 Health Care Stocks Slumping in 2013at Motley Fool (Thu, Feb 14)
• After Stock Plunges, Maybe Affymax News Isn't So Bad?at Minyanville (Thu, Feb 14)
• Affymax: Dialysis Provider Pauses Omontys Pilot Expansion, Dead Money For Nowat Seeking Alpha (Thu, Feb 14)
• Affymax Hit Hard... and Then Rebounds?at Motley Fool (Thu, Feb 14)
• U.S. Stock Options With Biggest Changes in Implied Volatilityat Bloomberg (Thu, Feb 14)
• Apple’s Name Registration Denied in Brazil and 4 Hot Stocks Making Wavesat Wall St. Cheat Sheet (Thu, Feb 14)
• AFFYMAX INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Feb 14)

Sunday, February 10, 2013

• Has Amgen Become the Perfect Stock?at Motley Fool (Sun, Feb 10)

Wednesday, February 6, 2013

• Affymax to Present at the BIO CEO & Investor ConferenceBusiness Wire (Wed, Feb 6)
• Q4 Omontys Sales Disappoint, Affymax Headed Lowerat Seeking Alpha (Wed, Feb 6)

Tuesday, February 5, 2013

• January Top 10: Keryxat Motley Fool (Tue, Feb 5)
• AFFYMAX INC Files SEC form 8-K, Other EventsEDGAR Online (Tue, Feb 5)

Friday, February 1, 2013

• AFFYMAX INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Fri, Feb 1)
• Affymax Announces Updates to Senior Leadership TeamBusiness Wire (Fri, Feb 1)

Thursday, January 31, 2013

• U.S. Stock Options With Biggest Changes in Implied Volatilityat Bloomberg (Thu, Jan 31)

Wednesday, January 30, 2013

• Keryx: This Biotech Is No Zombieat Motley Fool (Wed, Jan 30)

Thursday, January 24, 2013

• VIX - Options Volatility And Market Sonar: Thursday Recapat Seeking Alpha (Thu, Jan 24)
• Amgen Earnings: Beyond the Numbersat Motley Fool (Thu, Jan 24)
• New England Journal Of Medicine Articles Affirm Comparability Of Affymax's Omontys To Epogenat Seeking Alpha (Thu, Jan 24)

Add AFFY News to My Yahoo!